Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Pasternak

Showing results (71-80 of 85) with videos related to

Pageof 9
Sort By:
Journal of Molecular Biology|October 20, 1999
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppelR C Moore, I Y Lee, G L Silverman, et al.
Journal of Neurology|May 8, 2024
History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairmentMarc A Khoury, Nathan W Churchill, Alex Di Battista, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Journal of Neurology|May 25, 2025
Association between vascular risk factors burden and neurodegenerative diseases: results from ONDRIManuel Montero-Odasso, Frederico Pieruccini-Faria, Sandra E Black, et al.
International Journal of Geriatric Psychiatry|April 17, 2025
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson DiseaseNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 YearsArunima Kapoor, Robert Bartha, Sandra E Black, et al.
Molecular Genetics & Genomic Medicine|June 6, 2022
Targeted copy number variant identification across the neurodegenerative disease spectrumAllison A Dilliott, Kristina K Zhang, Jian Wang, et al.
NPJ Genomic Medicine|September 29, 2021
Contribution of rare variant associations to neurodegenerative disease presentationAllison A Dilliott, Abdalla Abdelhady, Kelly M Sunderland, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
Pageof 9

Showing results (71-80 of 85) with videos related to

Sort By:
Pageof 9
Journal of Molecular Biology|October 20, 1999
Ataxia in prion protein (PrP)-deficient mice is associated with upregulation of the novel PrP-like protein doppelR C Moore, I Y Lee, G L Silverman, et al.
Journal of Neurology|May 8, 2024
History of traumatic brain injury is associated with increased grey-matter loss in patients with mild cognitive impairmentMarc A Khoury, Nathan W Churchill, Alex Di Battista, et al.
The Lancet. Neurology|January 25, 2025
Intranasal oxytocin for apathy in people with frontotemporal dementia (FOXY): a multicentre, randomised, double-blind, placebo-controlled, adaptive, crossover, phase 2a/2b superiority trialKristy K L Coleman, Scott Berry, Jeffrey Cummings, et al.
Journal of Neurology|May 25, 2025
Association between vascular risk factors burden and neurodegenerative diseases: results from ONDRIManuel Montero-Odasso, Frederico Pieruccini-Faria, Sandra E Black, et al.
International Journal of Geriatric Psychiatry|April 17, 2025
A Cross Sectional and Longitudinal Assessment of Neuropsychiatric Symptoms and Brain Functional Connectivity in Patients With Mild Cognitive Impairment, Cerebrovascular Disease and Parkinson DiseaseNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
JAMA Neurology|June 30, 2025
Ambroxol as a Treatment for Parkinson Disease Dementia: A Randomized Clinical TrialCarolina R A Silveira, Kristy K L Coleman, Kathy Borron, et al.
Journal of Alzheimer'S Disease : JAD|March 3, 2020
Structural Brain Magnetic Resonance Imaging to Rule Out Comorbid Pathology in the Assessment of Alzheimer's Disease Dementia: Findings from the Ontario Neurodegenerative Disease Research Initiative (ONDRI) Study and Clinical Trials Over the Past 10 YearsArunima Kapoor, Robert Bartha, Sandra E Black, et al.
Molecular Genetics & Genomic Medicine|June 6, 2022
Targeted copy number variant identification across the neurodegenerative disease spectrumAllison A Dilliott, Kristina K Zhang, Jian Wang, et al.
NPJ Genomic Medicine|September 29, 2021
Contribution of rare variant associations to neurodegenerative disease presentationAllison A Dilliott, Abdalla Abdelhady, Kelly M Sunderland, et al.
International Journal of Geriatric Psychiatry|March 16, 2024
Neuropsychiatric symptoms and brain morphology in patients with mild cognitive impairment, cerebrovascular disease and Parkinson disease: A cross sectional and longitudinal studyNeda Rashidi-Ranjbar, Nathan W Churchill, Sandra E Black, et al.
Pageof 9